Coronary artery disease in patients after orthotopic heart transplantation treated with percutaneous coronary intervention - a single centre's experience

被引:0
作者
Sobieszczanska-Malek, Malgorzata [1 ]
Zielinski, Tomasz
Karcz, Maciej [2 ]
Piotrowska, Malgorzata
Kalinczuk, Lukasz [3 ]
Komuda, Krzysztof
Bekta, Pawel [2 ]
Witkowski, Adam [2 ]
Ruzyllo, Witold [2 ]
Korewicki, Jerzy
机构
[1] Inst Kardiol, Klin Niewydolnosci Serca & Transplantol, Dept Heart Failure & Transplantol, PL-04628 Warsaw, Poland
[2] Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland
[3] Inst Cardiol, Dept Coronary Artery Dis & Struct Heart Dis, Warsaw, Poland
来源
POSTEPY W KARDIOLOGII INTERWENCYJNEJ | 2010年 / 6卷 / 04期
关键词
vasculopathy heart transplantation; coronary artery disease; percutaneous coronary intervention; CARDIAC ALLOGRAFT VASCULOPATHY; LUNG TRANSPLANTATION; INTERNATIONAL SOCIETY; REJECTION; REGISTRY; QUILTY; RISK;
D O I
10.5114/pwki.2010.17629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Some patients after orthotopic heart transplantation (OHT) develop coronary focal lesions and may need interventional therapy Aim To determine the frequency and time course of narrowing of epicardial coronary arteries in transplanted hearts potential risk factors and results of percutaneous coronary interventions Methods and results Demographic and coronary angiography data of 265 patients after OHT mean age 53 0 +/- 14 6 were analysed Significant focal narrowing of the coronary artery was diagnosed when there was a decrease of 50% or more of the lumen of the coronary artery Mean time from OHT to the end of observation was 6 2 +/- 4 5 (range 0 5 23) years Thirty six (14%) patients after OHT had significant focal changes in coronary arteries In 16 patients the degree of stenosis lesion location or calibre of the vessel was not suitable for interventional therapy Twenty (55% 18 men) patients underwent coronary intervention Mean age of patients during coronary intervention was 53 5 +/- 9 8 years and of those without intervention at the end of observation was 52 5 +/- 14 9 years (NS) In patients with intervention mean time from OHT to intervention was 7 0 +/- 4 6 years In patients with coronary intervention mean time from OHT to the end of observation was 10 8 6 5 years and in patients without intervention 5 8 +/- 4 1 (p < 0 001) Analysis of Kaplan Meier curves showed that probability of coronary stenosis free survival diminishes rapidly after 5 years following OHT Patients who required coronary intervention had significantly higher hsCRP as compared to those without intervention (0 720 vs 0 044 p = 0 025) There were no statistical differences between the two groups in cholesterol level BMI or incidence of diabetes number of acute cellular episodes or Quilty effect Conclusions Significant focal coronary stenoses are found mainly more than 5 years post heart transplantation Most patients can be treated safely and effectively with percutaneous coronary intervention with contrast induced nephropathy prophylaxis Risk factors of coronary vasculopathy post OHT require further investigations
引用
收藏
页码:161 / 166
页数:6
相关论文
共 18 条
  • [11] Allosensitization in heart transplantation: implications and management strategies
    Mehra, MR
    Uber, PA
    Uber, WE
    Scott, RL
    Park, MH
    [J]. CURRENT OPINION IN CARDIOLOGY, 2003, 18 (02) : 153 - 158
  • [12] Allograft vasculopathy versus atherosclerosis
    Rahmani, Maziar
    Cruz, Rani P.
    Granville, David J.
    McManus, Bruce M.
    [J]. CIRCULATION RESEARCH, 2006, 99 (08) : 801 - 815
  • [13] Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection
    Stewart, S
    Winters, GL
    Fishbein, MC
    Tazelaar, HD
    Kobashigawa, J
    Abrams, J
    Andersen, CB
    Angelini, A
    Berry, GJ
    Burke, MM
    Demetris, AJ
    Hammond, E
    Itescu, S
    Marboe, CC
    McManus, B
    Reed, EF
    Reinsmoen, NL
    Rodriguez, ER
    Rose, AG
    Rose, M
    Suciu-Focia, N
    Zeevi, A
    Billingham, ME
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11) : 1710 - 1720
  • [14] Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy
    Tanaka, K
    Li, HY
    Curran, PJ
    Takano, Y
    Arbit, B
    Currier, JW
    Yeatman, LA
    Kobashigawa, JA
    Tobis, JM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (08) : 1192 - 1197
  • [15] Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009
    Taylor, David O.
    Stehlik, Josef
    Edwards, Leah B.
    Aurora, Paul
    Christie, Jason D.
    Dobbels, Fabienne
    Kirk, Richard
    Kucheryavaya, Anna Y.
    Rahmel, Axel O.
    Hertz, Marshall I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (10) : 1007 - 1022
  • [16] T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease
    Tu, Wenwei
    Potena, Luciano
    Stepick-Biek, Pamela
    Liu, Lanxiang
    Dionis, Kira Y.
    Luikart, Helen
    Fearon, William F.
    Holmes, Tyson H.
    Chin, Clifford
    Cooke, John P.
    Valantine, Hannah A.
    Mocarski, Edward S.
    Lewis, David B.
    [J]. CIRCULATION, 2006, 114 (15) : 1608 - 1615
  • [17] Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma"
    Valantine, HA
    [J]. TRANSPLANTATION, 2003, 76 (06) : 891 - 899
  • [18] Stenting unprotected left main coronary artery stenosis in heart transplant patients - The good, bad, and the ugly
    Weston, MW
    Spoto, E
    Sommers, E
    Sears, N
    Novitzky, D
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (11) : 1228 - 1232